Pacific Biosciences Of California reported $-35.4M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Agilent USD 577M 77M Jun/2026
Bruker USD 143.2M 33.2M Jun/2026
Danaher USD 2.1B 257M Sep/2026
General Electric Aerospace USD 3.32B 265M Sep/2026
Illumina USD 330M 80M Jun/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quidel USD 148M 18.7M Sep/2026
Revvity USD 227.55M 629K Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
Standard Biotools USD -6.56M 1.45M Jun/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
Waters USD 554M 158M Sep/2026